Slashdot Mirror
Apple Has a Secret Team Working On Non-Invasive Diabetes Sensors (cnbc.com)
schwit1 quotes a report from CNBC: Apple has hired a small team of biomedical engineers to work at a nondescript office in Palo Alto, miles from corporate headquarters. They are part of a super secret initiative, initially envisioned by the late Apple co-founder Steve Jobs, to develop sensors that can non-invasively and continuously monitor blood sugar levels to better treat diabetes, according to three people familiar with the matter. Such a breakthrough would be a "holy grail" for life sciences. Many life sciences companies have tried and failed, as it's highly challenging to track glucose levels accurately without piercing the skin. The initiative is far enough along that Apple has been conducting feasibility trials at clinical sites across the Bay Area and has hired consultants to help it figure out the regulatory pathways, the people said.
schwit1 adds: "From a business aspect, the most interesting part of this venture might be how Apple combines its penchant for secrecy with maneuvering through those regulatory pathways. It's one thing to introduce another new bit of consumer electronics kit. It's an entirely other thing to get a medical device past the FDA."
schwit1 adds: "From a business aspect, the most interesting part of this venture might be how Apple combines its penchant for secrecy with maneuvering through those regulatory pathways. It's one thing to introduce another new bit of consumer electronics kit. It's an entirely other thing to get a medical device past the FDA."
If this is real, Apple is very much behind the times when it comes to both sensor technology and understanding of the medical device market. Trying a spectroscopic approach (which appears to be the case) is way out of date, that's a generation behind even the FDA cleared tests, and isn't going to compete with the new generation of sensors being developed now.
There are several approaches to continuous monitoring of glucose, going back more than 10 years.
Many of these technologies, particularly the non-invasive ones, are more available outside the US than inside. This has more to do with the way medical device manufacturers are paid than any technical limitation. Bluntly, being in the glucose monitoring business is a great way to lose a lot of money quickly. Yes, the market is big, but it's brutal. Apple's strength is not dominating low margin, highly regulated markets.